Skip to main content
. 2022 Jun 23;12:10685. doi: 10.1038/s41598-022-15029-5

Table 3.

Comparison of adjusted risks of BPPV recurrence among no recurrence, single recurrence, and multiple recurrence groups.

Risk factors Categories or units No recurrence vs multiple recurrence Single recurrence vs multiple recurrence P wald (df)
B Sig aOR (95% CI) B Sig aOR (95% CI)
Age < 60 0.18 0.837 1.19 (0.21–6.78) 0.26 0.797 1.30 (0.17–9.74) 0.888
Sex Male 1.15 0.294 3.15 (0.36–27) − 15.35 0.990 2.14E−7 0.989
Hypertension No 0.18 0.856 1.19 (0.17–8.33) 0.12 0.918 1.12 (0.11–11.24) 0.932
Diabetics No − 16.16 0.995 9.54E−8 − 16.81 0.995 4.98E−8 0.740
Orthostatic hypotension No − 15.71 0.000 1.50E−7 (1.77E−8 to 1.27E−6) − 14.86 3.48E−7 0.439
Medicationsa No − 15.75 0.000 1.44E−7 (4.07E−8 to 5.12E−7) − 16.72 5.47E−8 0.132

BPPV Benign paroxysmal positional vertigo, B unstandardized coefficient. Sig. significance probability, aOR adjusted odds ratio, CI confidence interval, df degrees of freedom.

aThe diseases of the drug-taking were arrhythmia, heart disease, antidepressant, thyroid disease, hypnotic and prostate disease.

p values were calculated using polychotomous logistic regression analysis or Wald test.

Bold values indicate statistical significance (p < 0.05).